Search results
Results from the WOW.Com Content Network
[1] [a] A neoplasm is an abnormal growth of tissue that usually forms a tissue mass. [2] [3] [4] Vaginal neoplasms may be solid, cystic or of mixed type. [5] Vaginal cancers arise from vaginal tissue, with vaginal sarcomas develop from bone, cartilage, fat, muscle, blood vessels or other connective or supportive tissue.
Right picture shows higher magnification, including hobnailing which is individual cells protruding into the lumen of glands. Cells may have up to moderate atypia: They may have conspicuous nucleoli, and up to 3x variation in nuclear sizes compared to each other. More atypical features indicate a high-grade serous carcinoma. [2]
It is composed of a collection of abnormal endometrial cells, arising from the glands that line the uterus, which have a tendency over time to progress to the most common form of uterine cancer—endometrial adenocarcinoma, endometrioid type.
A papillary hidradenoma, also termed hidradenoma papilliferum or mammary-like gland adenoma of the vulva, [1] is a rare, but nonetheless most common benign tumor that occurs in and between anal and genital regions (i.e. anogenital area) of females. [2]
The cause of CIN is chronic infection of the cervix with HPV, especially infection with high-risk HPV types 16 or 18. It is thought that the high-risk HPV infections have the ability to inactivate tumor suppressor genes such as the p53 gene and the RB gene, thus allowing the infected cells to grow unchecked and accumulate successive mutations, eventually leading to cancer.
Cancer starts when new cells form unneeded, and old or damaged cells do not die as they should. The buildup of extra cells often forms a mass of tissue called an ovarian tumor or growth. These abnormal cancer cells have many genetic abnormalities that cause them to grow excessively. [56]
The search engine that helps you find exactly what you're looking for. Find the most relevant information, video, images, and answers from all across the Web.
In the United States, uterine cancer is the most common invasive gynecologic cancer. [22] The number of women diagnosed with uterine cancer has been steadily increasing, with 35,040 diagnosed in 1999 and 56,808 diagnosed in 2016. The age-adjusted rate of new cases in 1999 was 23.9 per 100,000 and has increased to 27.3 per 100,000 in 2016. [26]